戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 ponse was defined as a 15% reduction in left ventricular end-systolic volume.
2 MSC group, because of a preservation of left ventricular end-systolic volume.
3 e brain natriuretic peptide levels, and left ventricular end-systolic volume.
4               The primary end point was left ventricular end-systolic volume.
5 ic volume (0.01 mm/mL; P<0.01), a lower left ventricular end-systolic volume (-0.01 mm/mL; P=0.01), a
6                      SMT decreased both left ventricular end-systolic volume (10.4 +/- 2 to 7.7 +/- 4
7  and was associated with a reduction in left ventricular end-systolic volume (-24.8 +/- 3.0 ml vs. -8
8 unction as indicated by an increase in right ventricular end-systolic volume (54 +/- 10 to 87 +/-6 mL
9 ic volume (-49+/-16% versus -35+/-20%), left ventricular end-systolic volume (-59+/-20 versus -37+/-2
10 ignificant differences were observed in left ventricular end-systolic volumes (-6.4 mL [95% CI, -18.8
11 ctions (42% versus 69%), higher indexed left ventricular end-systolic volumes (96 versus 40 mL), and
12 stolic and end-diastolic dimensions and left ventricular end-systolic volume also decreased after 12
13 with pulmonary regurgitation, elevated right ventricular end systolic volumes and reduced right and l
14 VEF) and the noninvasive calculation of left ventricular end-systolic volume and left ventricular end
15  left ventricular end-diastolic volume, left ventricular end-systolic volume, and left ventricular ej
16  left ventricular end-diastolic volume, left ventricular end-systolic volume, and LVEF were not stati
17  S-LVRR (defined as >/=15% reduction in left ventricular end-systolic volume at 1-year of follow-up)
18 dians (quartiles 1 and 3) for change in left ventricular end-systolic volume at 6 months for the Smar
19         No difference in improvement in left ventricular end-systolic volume at 6 months was observed
20 sponse was defined as >15% reduction in left ventricular end-systolic volume at 6 months.
21 osite score and > or = 15% reduction in left ventricular end-systolic volume at 6 months.
22                The effect of cooling on left ventricular end-systolic volume at a pressure of 100 mm
23 ft ventricular contractility increased (left ventricular end-systolic volume at a pressure of 100 mm
24 actility was assessed by the calculated left ventricular end-systolic volume at an end-systolic left
25 ollow-up echocardiography compared with left ventricular end-systolic volume at baseline.
26 ic volume (beta=0.01/mL; P<0.0001), and left ventricular end-systolic volume (beta=0.01/mL; P<0.001)
27  left ventricular end-diastolic volume, left ventricular end-systolic volume, cardiac index, dP/dt ma
28 mproved in 69% of 426 patients, whereas left ventricular end-systolic volume decreased > or = 15% in
29        Echocardiographic assessments of left ventricular end-systolic volume, end-diastolic volume, m
30  during the first month (120% increased left ventricular end-systolic volume [ESV; P<0.01]), but shun
31                             A change in left ventricular end-systolic volume from intermediate stage
32 ess of CRT was defined as a decrease in left ventricular end-systolic volume &gt;15% at follow-up echoca
33 ated with the right atrial volume than right ventricular end-systolic volume in AF-TR (P<0.001).
34                  Isoprenaline decreased left ventricular end-systolic volume in wild-type hearts (10.
35 aced QRS duration, and smaller baseline left ventricular end systolic volume index also were also ass
36 d from 29 +/- 10.4 to 39 +/- 12.4%, and left ventricular end systolic volume index decreased from 109
37 hanges in the clinical composite score, left ventricular end systolic volume index, 6-minute walk tim
38 lume index (-26.2 versus -7.4 mL/m(2)), left ventricular end-systolic volume index (-28.7 versus -9.1
39 ) at follow-up; p = 0.0012), as did the left ventricular end-systolic volume index (48.4 +/- 19.7 ml/
40           The primary end point was the left ventricular end-systolic volume index (LVESVI) at 12 mon
41                                     The left ventricular end-systolic volume index (LVESVI) decreased
42  found no significant difference in the left ventricular end-systolic volume index (LVESVI) or surviv
43                         Patients with a left ventricular end-systolic volume index (LVESVI) reduction
44           Longitudinal data analysis of left ventricular end-systolic volume index (LVESVi) was perfo
45           The primary end point was the left ventricular end-systolic volume index (LVESVI), a measur
46  found no significant difference in the left ventricular end-systolic volume index (LVESVI), survival
47 ienced a 25.3-mL/m(2) mean reduction in left ventricular end-systolic volume index (P<0.0001), wherea
48 0.01) and was associated with increased left ventricular end-systolic volume index (r=0.62, P<0.01),
49 nt MRI predictors of death (P < 0.01): right ventricular end-systolic volume index adjusted for age a
50    In a multivariable regression model, left ventricular end-systolic volume index and left atrial vo
51                                        Right ventricular end-systolic volume index and left ventricul
52 p = 0.004), but not when combined with right ventricular end-systolic volume index and strain-rate e'
53                                         Left ventricular end-systolic volume index remained unchanged
54 vorably affected by VNS (p < 0.05), but left ventricular end-systolic volume index was not different
55 as also a strong predictor of change in left ventricular end-systolic volume index with monotonic inc
56 ight ventricular dilatation (increased right ventricular end-systolic volume index), high Acute Physi
57 t age, sex, ST or T changes on ECG, and left ventricular end-systolic volume index, LGE maintained a
58 MVR group compared with the CABG group: left ventricular end-systolic volume index, MR volume, and pl
59 ox regression analyses, the MRI-derived left ventricular end-systolic volume index, RV, and OMR categ
60 erapy, or a 15% or more increase in the left ventricular end-systolic volume index.
61                              Corrected right ventricular end-systolic volume is a strong prognostic m
62 r (CRT-D), defined as reduction in both left ventricular end-systolic volume (LVESV) and left atrial
63 lar end-diastolic volume (LVEDV) index, left ventricular end-systolic volume (LVESV) index, and LVEF
64      The primary endpoint was change in left ventricular end-systolic volume (LVESV) on cardiac magne
65 entricular ejection fraction (LVEF) and left ventricular end-systolic volume (LVESV) relative to base
66 as measured as reductions in atrial and left ventricular end-systolic volumes (LVESV) at 1 year.
67 % and <25% reductions, respectively, in left ventricular end-systolic volume [LVESV] at 1 year compar
68 d for age, sex, and body surface area, right ventricular end-systolic volume (P=0.004) strongly predi
69  patients with crypts had lower indexed left ventricular end-systolic volumes (P=0.042) and higher in
70 ng (left ventricular ejection fraction, left ventricular end-systolic volume), plus clinical outcomes
71                                         Left ventricular end-systolic volume progressively increased
72 ; P<0.001) and related to the change in left ventricular end-systolic volume (r=-0.53; P<0.001).
73 estimate, 21.34 mL; bias, -4.93 mL) and left ventricular end-systolic volume (r=0.96; standard error
74 egments at peak stress, and an abnormal left ventricular end-systolic volume response to stress were
75 ranging from 35% to 91%; for predicting left ventricular end-systolic volume response, sensitivity ra
76 etralogy of Fallot in women had larger right ventricular end-systolic volumes (standard deviation sco
77 tricular ejection fraction, from which right ventricular end-systolic volume was derived, was measure
78 left ventricular end-diastolic volume, while ventricular end-systolic volume was reduced by 24 +/- 6%
79 owed that incremental 10% reductions in left ventricular end-systolic volume were associated with cor
80 hic variables, especially the change in left ventricular end-systolic volume with exercise and the ex

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。